Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable phosphatidylinositol-5-phosphate binding activity. Predicted to be involved in negative regulation of SMAD protein signal transduction and negative regulation of transforming growth factor beta receptor signaling pathway. Predicted to be active in plasma membrane. Is expressed in several structures, including central nervous system; eye; gonad; gut; and immune system. Orthologous to human VEPH1 (ventricular zone expressed PH domain containing 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.